4//SEC Filing
STONE HEISZ LESLIE 4
Accession 0001225208-25-001709
CIK 0001099800other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 6:04 PM ET
Size
8.6 KB
Accession
0001225208-25-001709
Insider Transaction Report
Form 4
STONE HEISZ LESLIE
Director
Transactions
- Sale
Common Stock
2025-02-13$75.86/sh−5,739$435,371→ 30,035 total - Exercise/Conversion
Director Stock Option (Right to Acquire)
2025-02-13−5,739→ 0 totalExercise: $45.32From: 2018-05-18Exp: 2025-05-17→ Common Stock (5,739 underlying) - Exercise/Conversion
Common Stock
2025-02-13$45.32/sh+5,739$260,073→ 35,774 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $75.42 to $76.37. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001235408
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 6:04 PM ET
- Size
- 8.6 KB